Madrigal Pharma (MDGL) – Trading Halts
-
Madrigal Pharma (MDGL) Confirms FDA Approval of Rezdiffra for Treatment of Patients with Noncirrhotic NASH with Moderate to Advanced Liver Fibrosis
-
Madrigal Gets FDA Approval For NDA For Rezdiffra
-
-
-
Back to MDGL Stock Lookup